On Oct 20, 2016, a statement appeared on the WHO website, announcing that "An independent review commissioned by WHO has found that research ethics misconduct occurred in a study on foetal growth standards." 1 The study in question was the INTERGROWTH-21st study, led by researchers at the University of Oxford, UK, funded by the Bill & Melinda Gates Foundation (BMGF), and reported in several journals, including our own. [2] [3] [4] [5] Such a judgment by the world's foremost global health agency was serious, casting damaging light on a study of international importance.
On Nov 16, 2016, we wrote to Ian Smith, Executive Director of the Offi ce of the WHO Director-General, to request a copy of the review report, but were told that it was confi dential and had been supplied only to the University of Oxford, BMGF, and the UK General Medical Council, which was considering whether to open an investigation of its own.
We then wrote, on Nov 23, 2016, to the researchers, Stephen Kennedy and José Villar at the University of Oxford, to request their response to the review's fi ndings. We subsequently received a letter from the University's Registrar, Ewan McKendrick, reiterating the history of the dispute, which (as we were aware) dates back to 2008 and has been the subject of previous investigations by the University of Oxford, the Committee on Publication Ethics (COPE), and other journals. In brief, the dispute surrounds allegations of plagiarism and disputes over intellectual ownership concerning two research protocols with joint origins: those of the International Fetal and Newborn Growth Consortium for the 21st Century McKendrick's responses to us, on Nov 29, 2016, and Dec 13, 2016, were robust. It is clear from this response that the University of Oxford looked into these serious allegations at a high level, methodically dissected the claims, closely examined four pairs of protocols at diff erent stages of development, engaged with the WHO Director-General, and retrieved supporting documentation before concluding that the allegations were unfounded. The Oxford researchers clearly stated the methodological foundations of INTERGROWTH21st in their reports.
We were aware, however, that we had only heard the University's version of events, and again pressed WHO for their inquiry report. This document was eventually shared with us in confi dence on Jan 16, 2017, but we found it disappointingly insubstantial. We have therefore concluded that its far-reaching judgment of research misconduct is unproven, and gives no cause for concern regarding the reliability of the published data.
Research misconduct and the INTERGROWTH-21st study
Plagiarism of words and ideas is a serious academic off ence. However, on the basis of the evidence we have seen, we cannot agree that an idea (namely the construction of growth curves for fetuses) has been plagiarised from WHO: an international group of experts (including Villar) posed the question in 1995. 6 Furthermore, building on work that has gone before is what drives advances in knowledge. As for the overlap between the protocols, we have not repeated the direct comparisons of the University of Oxford and the WHO independent expert review panel, the former having produced percentage overlap data and critical content analysis. However, recent publication of the headline growth curves from the WHO Multicentre Study 8 indicates that the key aims were somewhat diff erent: while INTERGROWTH-21st only reports ultrasound measures of head circumference, biparietal diameter, occipitofrontal diameter, abdominal circumference, and femur length, the WHO Multicentre Study additionally shows estimated fetal weight.
The episode seems to us a sad example of academic rivalry and miscommunication, one that has been repeatedly investigated and previously put to rest. As far as we can ascertain, the recent inquiry by the WHO independent expert review panel has shed no new light on the matter and does not give us any reason at this stage to question the veracity of the papers we have published. 
